Recognition of NY-ESO-1+ tumor cells by engineered lymphocytes is enhanced by improved vector design and epigenetic modulation of tumor antigen expression

Jennifer A. Wargo, Paul F. Robbins, Yong Li, Yangbing Zhao, Mona El-Gamil, Diana Caragacianu, Zhili Zheng, Julie A. Hong, Stephanie Downey, David S. Schrump, Steven A. Rosenberg, Richard A. Morgan

Research output: Contribution to journalArticlepeer-review

66 Scopus citations

Fingerprint

Dive into the research topics of 'Recognition of NY-ESO-1+ tumor cells by engineered lymphocytes is enhanced by improved vector design and epigenetic modulation of tumor antigen expression'. Together they form a unique fingerprint.

Medicine & Life Sciences